{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:40:11Z","timestamp":1777642811055,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["JAMA Facial Plast Surg"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Exploring methods of potentially improving patient comfort and pain control in cosmetic facial surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the effects of celecoxib in reducing pain and possible opioid consumption following face-lift surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>We reviewed the medical records of 100 patients: 50 consecutive patients who underwent a face-lift without receiving perioperative celecoxib and 50 patients who underwent face-lift and received immediate preoperative and standing postoperative celecoxib.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>In addition to demographic information, the following outcome measures were recorded for each group: visual analog scale patient-reported pain, acetaminophen and\/or opioid consumption rates, and related analgesic adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The participants in the noncelecoxib vs celecoxib groups had similar demographic characteristics: mean age, 59.6 vs 57.9 years; mean BMI, 23.3 vs 22.3; history of chronic pain or opioid use, 7 (14%) vs 6 (12%); and 94% of both groups were women. Postoperative pain scores were higher in the noncelecoxib vs celecoxib groups; mean (SD) overall pain score was 3.88 (2.20) vs 2.31 (2.36) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001). The noncelecoxib group had a higher number of postoperative opioid doses than did the celecoxib group: 9.40 (4.30) vs 5.18 (4.58) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.05). The noncelecoxib group had a higher incidence of postoperative nausea and vomiting: 12 (24%) vs 0 in the celecoxib group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Preemptive treatment with oral celecoxib appears to be effective in decreasing acute postoperative pain and opioid consumption in patients undergoing face-lift. Given the well-documented adverse effects of opioids, celecoxib is a desirable alternative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/archfaci.jamanetwork.com\/public\/instructionsForAuthors.aspx#SecLevelofEvidence\">3<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamafacial.2014.351","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T18:31:42Z","timestamp":1405017102000},"page":"306-309","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["The Efficacy of Oral Celecoxib for Acute Postoperative Pain in Face-lift Surgery"],"prefix":"10.1177","volume":"16","author":[{"given":"Behrad B.","family":"Aynehchi","sequence":"first","affiliation":[{"name":"Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology\u2013Head and Neck Surgery, Lenox Hill Hospital, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric W.","family":"Cerrati","sequence":"additional","affiliation":[{"name":"Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology\u2013Head and Neck Surgery, Lenox Hill Hospital, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology\u2013Head and Neck Surgery, Lenox Hill Hospital, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"e_1_3_1_2_2","unstructured":"American Society of Plastic Surgeons. 2012 Plastic Surgery Procedural Statistics. www.plasticsurgery.org. Accessed December 3 2013."},{"issue":"2","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00266-010-9567-x","article-title":"Modified superficial musculoaponeurotic system face-lift: a review of 327 consecutive procedures and a patient satisfaction assessment.","volume":"35","author":"Castello MF","year":"2011","unstructured":"Castello MF, , Lazzeri D, , Silvestri A, . Modified superficial musculoaponeurotic system face-lift: a review of 327 consecutive procedures and a patient satisfaction assessment. Aesthetic Plast Surg. 2011; 35(2):147-155. 20871998","journal-title":"Aesthetic Plast Surg"},{"issue":"5","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/00006534-199910000-00015","article-title":"Optimization of conscious sedation in plastic surgery.","volume":"104","author":"Marcus JR","year":"1999","unstructured":"Marcus JR, , Tyrone JW, , Few JW, , Fine NA, , Mustoe TA. Optimization of conscious sedation in plastic surgery. Plast Reconstr Surg. 1999; 104(5):1338-1345. 10513915","journal-title":"Plast Reconstr Surg"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpa.2014.03.001"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200203000-00019"},{"issue":"5","key":"e_1_3_1_7_2","first-page":"1048","article-title":"The value of \u201cmultimodal\u201d or \u201cbalanced analgesia\u201d in postoperative pain treatment.","volume":"77","author":"Kehlet H","year":"1993","unstructured":"Kehlet H, , Dahl JB. The value of \u201cmultimodal\u201d or \u201cbalanced analgesia\u201d in postoperative pain treatment. Anesth Analg. 1993; 77(5):1048-1056. 8105724","journal-title":"Anesth Analg"},{"issue":"18","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.290.18.2411","article-title":"Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial.","volume":"290","author":"Buvanendran A","year":"2003","unstructured":"Buvanendran A, , Kroin JS, , Tuman KJ, . Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA. 2003; 290(18):2411-2418. 14612477","journal-title":"JAMA"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2005.00666.x"},{"issue":"12","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1538-7836.2007.02782.x","article-title":"Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.","volume":"5","author":"Graff J","year":"2007","unstructured":"Graff J, , Skarke C, , Klinkhardt U, . Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers. J Thromb Haemost. 2007; 5(12):2376-2385. 17916229","journal-title":"J Thromb Haemost"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2012.01.020"},{"issue":"2","key":"e_1_3_1_12_2","first-page":"102","article-title":"Review of the cardiovascular safety of COXIBs compared to NSAIDS.","volume":"19","author":"Moodley I","year":"2008","unstructured":"Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr. 2008; 19(2):102-107. 18516356","journal-title":"Cardiovasc J Afr"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2474-9-77","article-title":"Perioperative celecoxib administration for pain management after total knee arthroplasty: a randomized, controlled study.","volume":"9","author":"Huang YM","year":"2008","unstructured":"Huang YM, , Wang CM, , Wang CT, , Lin WP, , Horng LC, , Jiang CC. Perioperative celecoxib administration for pain management after total knee arthroplasty: a randomized, controlled study. BMC Musculoskelet Disord. 2008; 9:77. 18519002","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00402-013-1852-0","article-title":"Celecoxib as a pre-emptive analgesia after arthroscopic knee surgery: a triple-blinded randomized controlled trial.","volume":"133","author":"Mardani-Kivi M","year":"2013","unstructured":"Mardani-Kivi M, , Karimi Mobarakeh M, , Haghighi M, . Celecoxib as a pre-emptive analgesia after arthroscopic knee surgery: a triple-blinded randomized controlled trial. Arch Orthop Trauma Surg. 2013; 133(11):1561-1566. 24043481","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00266-008-9230-y","article-title":"Combined preoperative use of celecoxib and gabapentin in the management of postoperative pain.","volume":"33","author":"Parsa AA","year":"2009","unstructured":"Parsa AA, , Sprouse-Blum AS, , Jackowe DJ, , Lee M, , Oyama J, , Parsa FD. Combined preoperative use of celecoxib and gabapentin in the management of postoperative pain. Aesthetic Plast Surg. 2009; 33(1):98-103. 18712436","journal-title":"Aesthetic Plast Surg"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181618831"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-005-0032-1"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfaci.2012.2"},{"issue":"6","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archfaci.2009.82","article-title":"Defining the facial extent of the platysma muscle: a review of 71 consecutive face-lifts.","volume":"11","author":"Shah AR","year":"2009","unstructured":"Shah AR, , Rosenberg D. Defining the facial extent of the platysma muscle: a review of 71 consecutive face-lifts. Arch Facial Plast Surg. 2009; 11(6):405-408. 19917902","journal-title":"Arch Facial Plast Surg"}],"updated-by":[{"DOI":"10.1001\/jamafacial.2013.1725","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000}}],"container-title":["JAMA Facial Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1001\/jamafacial.2014.351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1001\/jamafacial.2014.351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1001\/jamafacial.2014.351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:24:14Z","timestamp":1777443854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1001\/jamafacial.2014.351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1001\/jamafacial.2014.351"],"URL":"https:\/\/doi.org\/10.1001\/jamafacial.2014.351","relation":{},"ISSN":["2168-6076","2168-6092"],"issn-type":[{"value":"2168-6076","type":"print"},{"value":"2168-6092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}